Next-generation antibody-based therapies in neurology

Ruck T, Nimmerjahn F, Wiendl H, Luenemann JD (2021)


Publication Type: Journal article, Review article

Publication year: 2021

Journal

DOI: 10.1093/brain/awab465

Abstract

Ruck et al. describe recent developments in next-generation antibody-based therapies for brain diseases, including progress in Fc engineering, and efforts to improve the bioavailability of antibody-based platforms in CNS parenchyma. They highlight the potential benefits as well as limitations of such therapies in neurology.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Ruck, T., Nimmerjahn, F., Wiendl, H., & Luenemann, J.D. (2021). Next-generation antibody-based therapies in neurology. Brain. https://doi.org/10.1093/brain/awab465

MLA:

Ruck, Tobias, et al. "Next-generation antibody-based therapies in neurology." Brain (2021).

BibTeX: Download